ASX - By Stock
|
IMM |
Re:
Ann: Positive initial data in phase 2 Soft Tissue Sarcoma trial
|
|
ajk92
|
15 |
6.0K |
7 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
15
|
6.0K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive initial data in phase 2 Soft Tissue Sarcoma trial
|
|
ajk92
|
15 |
6.0K |
4 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
15
|
6.0K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
TACTI-003 likelihood of success based on data comparison
|
|
ajk92
|
2 |
1.2K |
2 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
2
|
1.2K
|
2
|
|
ASX - By Stock
|
IMM |
TACTI-003 likelihood of success based on data comparison
|
|
ajk92
|
2 |
1.2K |
17 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
2
|
1.2K
|
17
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive preliminary topline results from TACTI-003 Cohort B
|
|
ajk92
|
51 |
22K |
9 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
51
|
22K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive preliminary topline results from TACTI-003 Cohort B
|
|
ajk92
|
51 |
22K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
51
|
22K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive preliminary topline results from TACTI-003 Cohort B
|
|
ajk92
|
51 |
22K |
11 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
51
|
22K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Marc do your job!
|
|
ajk92
|
42 |
17K |
3 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
42
|
17K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
ajk92
|
743 |
328K |
10 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
743
|
328K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
ajk92
|
316 |
160K |
6 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
316
|
160K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
ajk92
|
316 |
160K |
70 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
316
|
160K
|
70
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ajk92
|
9.9K |
4.4M |
16 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ajk92
|
9.9K |
4.4M |
22 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
22
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
ajk92
|
1.6K |
829K |
1 |
27/12/23 |
27/12/23 |
Charts
|
1.6K
|
829K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ajk92
|
9.9K |
4.4M |
7 |
26/12/23 |
26/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ajk92
|
9.9K |
4.4M |
17 |
26/12/23 |
26/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
17
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Resubmission of NDA for Sofdra Completed
|
|
ajk92
|
108 |
27K |
5 |
23/12/23 |
23/12/23 |
ASX - By Stock
|
108
|
27K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ajk92
|
9.9K |
4.4M |
2 |
23/12/23 |
23/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ajk92
|
9.9K |
4.4M |
8 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ajk92
|
9.9K |
4.4M |
13 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ajk92
|
9.9K |
4.4M |
16 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
ajk92
|
208 |
85K |
32 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
208
|
85K
|
32
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
ajk92
|
208 |
85K |
16 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
208
|
85K
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
ajk92
|
315 |
155K |
51 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
315
|
155K
|
51
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
ajk92
|
315 |
155K |
1 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
315
|
155K
|
1
|
|
ASX - By Stock
|
MGX |
Re:
December quarter predictions
|
|
ajk92
|
56 |
16K |
0 |
03/12/23 |
03/12/23 |
ASX - By Stock
|
56
|
16K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren completes Phelan-McDermid syndrome Phase 2 trial
|
|
ajk92
|
51 |
28K |
1 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
51
|
28K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ajk92
|
9.9K |
4.4M |
32 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
32
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
ajk92
|
947 |
473K |
15 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
947
|
473K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
DAYBUE BOOOOOM !!!!!!!!!!!
|
|
ajk92
|
42 |
17K |
6 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
42
|
17K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
DAYBUE BOOOOOM !!!!!!!!!!!
|
|
ajk92
|
42 |
17K |
14 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
42
|
17K
|
14
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Receives USFDA Approval for Technegas
|
|
ajk92
|
41 |
10K |
5 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
41
|
10K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
ajk92
|
8.1K |
3.0M |
2 |
01/10/23 |
01/10/23 |
ASX - By Stock
|
8.1K
|
3.0M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
ajk92
|
8.1K |
3.0M |
6 |
01/10/23 |
01/10/23 |
ASX - By Stock
|
8.1K
|
3.0M
|
6
|
|
ASX - By Stock
|
CYC |
Re:
Countdown
|
|
ajk92
|
65 |
18K |
0 |
30/09/23 |
30/09/23 |
ASX - By Stock
|
65
|
18K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
Countdown
|
|
ajk92
|
65 |
18K |
1 |
30/09/23 |
30/09/23 |
ASX - By Stock
|
65
|
18K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ajk92
|
9.9K |
4.4M |
12 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
12
|
|
ASX - By Stock
|
CVB |
Re:
Expectations - short term
|
|
ajk92
|
29 |
15K |
0 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
29
|
15K
|
0
|
|
ASX - By Stock
|
CVB |
Re:
Expectations - short term
|
|
ajk92
|
29 |
15K |
8 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
29
|
15K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ajk92
|
9.9K |
4.4M |
25 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
25
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ajk92
|
9.9K |
4.4M |
47 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
47
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ajk92
|
9.9K |
4.4M |
14 |
17/07/23 |
17/07/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ajk92
|
9.9K |
4.4M |
10 |
17/07/23 |
17/07/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
10
|
|
ASX - By Stock
|
NEU |
Re:
$4 Target
|
|
ajk92
|
129 |
40K |
1 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
129
|
40K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
$4 Target
|
|
ajk92
|
129 |
40K |
31 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
129
|
40K
|
31
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ajk92
|
9.9K |
4.4M |
20 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
20
|
|
ASX - By Stock
|
NEU |
Re:
$4 Target
|
|
ajk92
|
129 |
40K |
5 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
129
|
40K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Bubble boy
|
|
ajk92
|
68 |
20K |
4 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
68
|
20K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ajk92
|
9.9K |
4.4M |
15 |
23/03/23 |
23/03/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
15
|
|
ASX - By Stock
|
DYL |
Re:
DYL chart
|
|
ajk92
|
125 |
50K |
0 |
20/03/23 |
20/03/23 |
ASX - By Stock
|
125
|
50K
|
0
|
|